Advertisement

Rheumatology International

, Volume 1, Issue 4, pp 177–180 | Cite as

Anti-RANA antibody in rheumatoid arthritis, seronegative polyarthritis, and normal controls

  • S. A. LeClercq
  • P. Davis
Originals
  • 16 Downloads

Summary

Anti-RANA antibody was found in 76% and 69% of seropositive and seronegative rheumatoid patients. No correlation appeared between this antibody, rheumatoid factor or a positive fluorescent anti-nuclear antibody (FANA). Many sera from healthy individuals, paritcularly medical personnel, and other disease groups demonstrated the fine nuclear speckling by immunofluorescence on Raji cells, but with weaker fluorescence. Anti-IgG conjugate was more sensitive in detecting the presence of the antibody in these sera. The presence of other antibodies producing a diffuse nuclear fluorescent pattern on Raji cells made it difficult to assess underlying fine nuclear speckling. Many of these sera produced a positive FANA on rat liver substrate. Very little variation in anti-RANA antibody status occurred with time and any change that did occur did so independently of rheumatoid factor. In view of the presence of anti-RANA antibody in the sera of patients with a variety of underlying rheumatic disorders and in normal individuals, the exact role of the antibody in the pathogenesis or diagnosis of rheumatoid arthritis is in doubt.

Key words

Anti-RANA antibody Rheumatoid arthritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in sjogren's syndrome. J Clin Invest 55:1067–1073Google Scholar
  2. 2.
    Alspaugh MA, Talal N, Tan EM (1976) Differentiation and characterization of autoantibodies and their antigens in sjogren's syndrome. Arthritis Rheum 19:216–222Google Scholar
  3. 3.
    Alspaugh MA, Tan EM (1976) Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen-demonstration by precipitation and immunofluorescence. Arthritis Rheum 19:711–719Google Scholar
  4. 4.
    Alspaugh MA, Jensen FC, Rabin H, Tan EM (1978) Lymphocytes transformed by Epstein-Barr virus — induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147:1018–1027Google Scholar
  5. 5.
    Vaughan JH (1979) Dunlop-Dottridge Lecture — rheumatoid arthritis, rheumatoid factor and the Epstein-Barr virus. J Rheumatol 6:381–387Google Scholar
  6. 6.
    Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH (1979) Antibodies to Epstein-Barr virus determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 76:5825–5828Google Scholar
  7. 7.
    Ng KC, Brown KA, Perry JD, Holborow EJ (1980) Anti-RANA antibody — a marker for seronegative and seropositive rheumatoid arthritis. Lancet I:447–449Google Scholar
  8. 8.
    Catalano MA, Carson DA, Nuderman JC, Feorino P, Vaughan JH (1980) Antibody to the rheumatoid arthritis nuclear antigen — its relationship to in vivo Epstein-Barr virus infection. J Clin Invest 65:1238–1242Google Scholar
  9. 9.
    Catalano MA, Carson DA, Stastny P, Freer S, Vaughan JH (1980) Correlation between anti-RANA and anti-EBNA in normal subjects with and without HLA-DRw4. Arthritis Rheum 23:1049–1052Google Scholar
  10. 10.
    Bardwick PA, Bluestein HG, Zvaifler NJ, Depper JM, Seegmiller JE (1980) Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum 23:626–632Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • S. A. LeClercq
    • 1
  • P. Davis
    • 1
  1. 1.Rheumatic Disease Unit, Department of MedicineUniversity of AlbertaEdmontonCanada

Personalised recommendations